DK1666473T3 - Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens - Google Patents

Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens

Info

Publication number: DK1666473T3
Authority: DK; Denmark
Prior art keywords: carboxylic acid; active ingredient; same; compositions containing; acid compounds
Prior art date: 2003-09-17

Application number

DK04773373.8T

Other languages

English (en)

Inventor

Atsushi Naganawa

Maki Iwahashi

Atsushi Kinoshita

Atsushi Shimabukuro

Seiji Ogawa

Koji Yano

Yutaka Okada

Shouji Kawauchi

Yoko Matsunaga

Kohki Tsukamoto

Fumio Nambu

Kaoru Kobayashi

Yoko Kishida

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-17

Filing date

2004-09-16

Publication date

2013-03-25

2004-09-16 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2013-03-25 Application granted granted Critical

2013-03-25 Publication of DK1666473T3 publication Critical patent/DK1666473T3/da

Links

-1 Carboxylic acid compounds Chemical class 0.000 title 1
239000004480 active ingredient Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Immunology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)

DK04773373.8T 2003-09-17 2004-09-16 Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens DK1666473T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2003325198		2003-09-17
JP2004101863		2004-03-31
PCT/JP2004/013983 WO2005028455A1 (ja)	2003-09-17	2004-09-16	カルボン酸化合物およびそれらを有効成分として含有する医薬組成物

Publications (1)

Publication Number	Publication Date
DK1666473T3 true DK1666473T3 (da)	2013-03-25

Family

ID=34380314

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04773373.8T DK1666473T3 (da)	2003-09-17	2004-09-16	Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens

Country Status (18)

Country	Link
US (2)	US7601712B2 (da)
EP (1)	EP1666473B1 (da)
JP (1)	JP4919143B2 (da)
KR (1)	KR20060080197A (da)
AU (1)	AU2004274324B2 (da)
BR (1)	BRPI0414487A (da)
CA (1)	CA2539070C (da)
DK (1)	DK1666473T3 (da)
ES (1)	ES2399393T3 (da)
IL (1)	IL174336A (da)
MX (1)	MXPA06002945A (da)
NO (1)	NO20061207L (da)
NZ (1)	NZ545934A (da)
PL (1)	PL1666473T3 (da)
PT (1)	PT1666473E (da)
RU (1)	RU2375353C2 (da)
TW (1)	TWI341838B (da)
WO (1)	WO2005028455A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20050092429A (ko) *	2003-01-22	2005-09-21	니찌방 가부시기가이샤	안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
HUE030850T2 (en)	2006-06-16	2017-06-28	Univ Pennsylvania	Prostaglandin D2 receptor antagonists for the treatment of hair loss
FR2903985B1 (fr)	2006-07-24	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
TWI410410B (zh) *	2007-08-10	2013-10-01	Ono Pharmaceutical Co	Phenylacetic acid compounds
DE102008059133A1 (de)	2008-11-26	2010-05-27	Merck Patent Gmbh	Difluorphenyl-diacylhydrazid-derivate
WO2016001452A1 (en)	2014-07-04	2016-01-07	Universität Zürich	Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated
RU2626829C2 (ru) *	2015-11-02	2017-08-02	Анатолий Тимофеевич Корабельников	Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
KR20220107330A (ko)	2018-09-20	2022-08-02	오노 야꾸힝 고교 가부시키가이샤	Dp 길항제
TW202114985A (zh) *	2019-06-28	2021-04-16	日商小野藥品工業股份有限公司	Ｅｐ拮抗劑
JP7047954B2 (ja) *	2020-03-19	2022-04-05	小野薬品工業株式会社	フェニル酢酸化合物を含有する医薬組成物
WO2021187547A1 (ja) *	2020-03-19	2021-09-23	小野薬品工業株式会社	フェニル酢酸化合物の結晶

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5764655A (en) *	1980-10-04	1982-04-19	Nippon Zoki Pharmaceut Co Ltd	Novel benzoylaminophenylcarboxylic acid derivative, its preparation, and drug composition comprising it
WO1986005779A1 (en) *	1985-04-03	1986-10-09	Yamanouchi Pharmaceutical Co., Ltd.	Phenylene derivatives
AU637500B2 (en) *	1990-06-21	1993-05-27	Zeneca Limited	Bicyclic heterocyclic compounds
US5696117A (en) *	1995-11-07	1997-12-09	Ortho Pharmaceutical Corporation	Benzoxazine antimicrobial agents
KR20030010589A (ko) *	2000-03-09	2003-02-05	오노 야꾸힝 고교 가부시키가이샤	인돌 유도체, 그 제조 방법 및 용도
CN100378083C (zh) *	2002-03-19	2008-04-02	小野药品工业株式会社	羧酸化合物和含有所述化合物作为活性成分的药物制剂
AU2003227325B2 (en) *	2002-08-02	2009-05-28	Scientific Games, Llc	Lottery ticket security method
BRPI0407258A (pt) *	2003-02-07	2006-01-31	Ono Pharmaceutical Co	Compostos de ácido carboxìlico
WO2004099170A2 (en)	2003-04-30	2004-11-18	The Institutes For Pharmaceutical Discovery, Llc	Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b

2004
- 2004-09-16 KR KR1020067005190A patent/KR20060080197A/ko not_active Withdrawn
- 2004-09-16 PL PL04773373T patent/PL1666473T3/pl unknown
- 2004-09-16 RU RU2006112573/04A patent/RU2375353C2/ru not_active IP Right Cessation
- 2004-09-16 TW TW093127979A patent/TWI341838B/zh not_active IP Right Cessation
- 2004-09-16 US US10/572,578 patent/US7601712B2/en not_active Expired - Fee Related
- 2004-09-16 EP EP04773373A patent/EP1666473B1/en not_active Expired - Lifetime
- 2004-09-16 WO PCT/JP2004/013983 patent/WO2005028455A1/ja not_active Ceased
- 2004-09-16 ES ES04773373T patent/ES2399393T3/es not_active Expired - Lifetime
- 2004-09-16 DK DK04773373.8T patent/DK1666473T3/da active
- 2004-09-16 BR BRPI0414487-2A patent/BRPI0414487A/pt active Search and Examination
- 2004-09-16 AU AU2004274324A patent/AU2004274324B2/en not_active Ceased
- 2004-09-16 PT PT47733738T patent/PT1666473E/pt unknown
- 2004-09-16 CA CA2539070A patent/CA2539070C/en not_active Expired - Fee Related
- 2004-09-16 MX MXPA06002945A patent/MXPA06002945A/es active IP Right Grant
- 2004-09-16 JP JP2005514124A patent/JP4919143B2/ja not_active Expired - Fee Related
- 2004-09-16 NZ NZ545934A patent/NZ545934A/en not_active IP Right Cessation
2006
- 2006-03-15 NO NO20061207A patent/NO20061207L/no not_active Application Discontinuation
- 2006-03-15 IL IL174336A patent/IL174336A/en not_active IP Right Cessation
2009
- 2009-09-01 US US12/551,860 patent/US8138335B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP4919143B2 (ja)	2012-04-18
RU2375353C2 (ru)	2009-12-10
IL174336A (en)	2012-01-31
AU2004274324A1 (en)	2005-03-31
TW200524886A (en)	2005-08-01
NO20061207L (no)	2006-06-19
US20100029631A1 (en)	2010-02-04
US7601712B2 (en)	2009-10-13
WO2005028455A1 (ja)	2005-03-31
CA2539070C (en)	2011-12-13
BRPI0414487A (pt)	2006-11-14
MXPA06002945A (es)	2006-06-14
CA2539070A1 (en)	2005-03-31
NZ545934A (en)	2009-05-31
EP1666473A1 (en)	2006-06-07
KR20060080197A (ko)	2006-07-07
PL1666473T3 (pl)	2013-05-31
RU2006112573A (ru)	2007-10-27
US8138335B2 (en)	2012-03-20
JPWO2005028455A1 (ja)	2006-11-30
US20070004716A1 (en)	2007-01-04
IL174336A0 (en)	2006-08-01
TWI341838B (en)	2011-05-11
EP1666473B1 (en)	2013-01-02
EP1666473A4 (en)	2009-06-03
ES2399393T3 (es)	2013-04-01
AU2004274324B2 (en)	2009-11-05
PT1666473E (pt)	2013-02-15

Publication	Publication Date	Title
NO20040564L (no)	2004-05-10	Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel
NO20043702L (no)	2004-12-03	8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
DK1498411T3 (da)	2013-04-15	Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
NO20042807L (no)	2004-07-02	Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
NO20043904L (no)	2004-11-11	Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens
DK1660104T3 (da)	2010-06-21	Farmaceutisk formulering indeholdende lanthanforbindelser
DK1564210T3 (da)	2009-11-16	4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer
EP1631239A4 (en)	2008-03-05	PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
DK1484970T3 (da)	2013-10-07	Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
DK1557415T3 (da)	2012-09-17	Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
IL229510A0 (en)	2013-12-31	A dosage form containing pantoprazole as an active ingredient
DK1608362T3 (da)	2007-05-14	Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
WO2004091591A3 (fr)	2004-11-25	Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
FI20031078A7 (fi)	2004-02-02	Antibioottisesti oletiivisia farmaseuttisia koostumuksia
NO20051956D0 (no)	2005-04-21	Salmeterol superfin formulering
IL174336A0 (en)	2006-08-01	Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
EP1669065A4 (en)	2009-12-16	DRUGS WITH (2R) -2-PROPYLOCTANIC ACID AS ACTIVE SUBSTANCE
NO20054214D0 (no)	2005-09-12	Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
IL179336A0 (en)	2007-03-08	Benzoic acid derivatives and pharmaceutical compositions containing the same
NO331227B1 (no)	2011-11-07	Lineaere basiske forbindelser som har NK-2 antagonistaktivitet, farmasoytiske formuleringer derav og anvendelse av samme for fremstilling av farmasoytiske formuleringer
IL174248A0 (en)	2006-08-01	Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
NO20041878D0 (no)	2004-05-07	Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
ITTO20020672A0 (it)	2002-07-26	Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
DE502004003170D1 (de)	2007-04-19	Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
AU2002363776A1 (en)	2003-07-24	Carboxylic acid derivative compounds and drugs containing the same as the active ingredient